The Cancer Genome Atlas

The Cancer Genome Atlas (TCGA) was a joint effort of the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), which are both part of the National Institutes of Health, U.S. Department of Health and Human Services. More information on TCGA can be found on NCI’s The Cancer Genome Atlas Program website.

The Cancer Genome Atlas began with a pilot to  assessed the feasibility of a full-scale effort to systematically explore the entire spectrum of genomic changes involved in human cancer.  The project then molecularly characterized over 20,000 primary cancer and matched noral samples from 33 cancer types. The over 2.5 petabytes of data generated through TCGA remain publicly available for anyone in the research community to use.

• NIH completes in-depth genomic analysis of 33 cancer types (2018)
   
• The Cancer Genome Atlas publishes results for bile duct, uterine and breast cancer (2017)
   
• TCGA study identifies genomic features of cervical cancer (2017)
   
• TCGA study reveals new clues to the genomic diversity of prostate cancers (2015)
   
• Peering at brain and skin cancers through a genomic lens, scientists begin to rewrite rules for identifying tumor types (2015)
   
• The Cancer Genome Atlas (TCGA): The next stage (2015)
   
• NIH-funded study uncovers range of molecular alterations in head and neck cancers, new potential drug targets (2015)
   
• TCGA study improves understanding of genetic drivers of thyroid cancer (2014)
   
• Rare kidney tumor provides insights on role of metabolic changes in cancerr (2014)
   
• TCGA researchers identify four subtypes of stomach cancerr (2014)
   
• Study identifies novel genomic changes in the most common type of lung cancerr (2014)
   
• TCGA bladder cancer study reveals potential drug targets, similarities to several cancersr (2014)
   
• As genomics breaches cancer walls, researchers forge new treatment pathsr (2014)
   
• TCGA study of glioblastoma tumor genome reveals new details, potential treatment strategies (2013)
   
• The benefits of looking across many cancer genomes: A perspective (2013)
   
• Kidney cancer progression linked to shifts in tumor metabolism (2013)
   
• Study establishes basis for genomic classification of endometrial cancers (2013)
   
• TCGA researchers identify potential drug targets, markers for leukemia risk (2013)
   
• Study reveals genomic similarities between breast cancer and ovarian cancers (2012)
   
• The Cancer Genome Atlas completes detailed ovarian cancer analysis (2011)
   
• Researchers discover key mutation in acute myeloid leukemia (2010)
   
• The Cancer Genome Atlas Identifies Distinct Subtypes of Deadly Brain Cancer That May Lead to New Treatment Strategies (2010)
   
• President Announces Major Recovery Act Funding for The Cancer Genome Atlas Project (2009)
   
• The Cancer Genome Atlas Reports First Results of Comprehensive Study of Brain Tumors (2008)
   
• The Cancer Genome Atlas Awards Funds for Technology Development (2007)
   
• National Institutes of Health to Map Genomic Changes of Lung, Brain, and Ovarian Cancers (2006)
   
• NIH Launches Comprehensive Effort to Explore Cancer Genomics (2005)
   
• News Conference Webcast (2005)

• TCGA Legacy: Multi-Omic Studies in Cancer
  September 27-29, 2018
   
• The Cancer Genome Atlas Fourth Annual Scientific Symposium
  May 11-12, 2015
   
• The Cancer Genome Atlas Third Annual Scientific Symposium
  May 12-13, 2014
   
• The Cancer Genome Atlas Second Annual Scientific Symposium
  November 27-28, 2012
   
• The Cancer Genome Atlas First Annual Scientific Symposium
  November 17-18, 2011

• The Cancer Genome Atlas Website
  The official website for The Cancer Genome Atlas
   
• The Cancer Genome Atlas Brochure
  An informational brochure about The Cancer Genome Atlas
   
• Mapping the Cancer Genome
  In the March 2007 issue of Scientific American, NHGRI Director Francis S. Collins and National Cancer Institute Deputy Director for Advanced Technologies and Strategic Partnerships Anna D. Barker find that pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies.
   
• Toward a Comprehensive Genomic Analysis of Cancer
  The report from a workshop co-organized by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) as part of their collaboration to initiate the pilot phase of the Human Cancer Genome Project (HCGP), July 20-22, 2005.
   
• Report to the National Cancer Advisory Board Report from the Advanced Biomedical Technology Working Group of the National Cancer Advisory Board (NCAB), February 16, 2005